Basketball legend Kareem Abdul-Jabbar has partnered with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AFib) and its symptoms as part of the No Time to Wait campaign.
In support of the campaign, Abdul-Jabbar will share his experience with AFib, including what led to his diagnosis, and encourage others to speak to a healthcare professional if they are having symptoms. Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, but many people remain undiagnosed because symptoms vary.
“When I first started to experience symptoms like shortness of breath and light-headedness, I dismissed them until they reached a point where I could no longer ignore them and I ended up in the hospital where I was diagnosed with AFib,” said Abdul-Jabbar in a press statement. “I”™ve joined the No Time to Wait campaign with Bristol Myers Squibb and Pfizer because I want my experience to help others understand the symptoms of AFib. Health is nothing to play around with. I hope my story can help motivate others to speak with a healthcare professional if they are experiencing symptoms.”
